Vertex invests in UK-based machine learning specialist

30 August 2018
2019_biotech_test_vial_discovery_big

Boston, USA-based Vertex Pharmaceuticals (Nasdaq: VRTX) and the UK’s Genomics have announced a three-year collaboration to use human genetics and machine learning to improve discovery of targets for precision medicines.

Vertex, which has also made a £10.5 ($14 million) equity investment in Genomics, will work with the Oxford-based company to “advance understanding of the clinical impact of human genetic variation and patient stratification in diseases with significant unmet need.”

The equity investment is part of a £25 million series B round, in which investors IP Group, Woodford Investment Management and Oxford Sciences Innovation (OSI) also participated, among others.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology